SCHEMBL27165384

SCHEMBL27165384

COc1ccc2cnn(C[C@@H]3CCCN3C)c2c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.51
▸ HTR2C P28335 1/20 0.51
▸ HTR2B P41595 1/20 0.51
▸ CHRM2 P08172 3/20 0.49
▸ CHRM1 P11229 3/20 0.49
▸ CHRNB4 P30926 4/20 0.49
▸ CHRNA3 P32297 4/20 0.49
▸ ADRA1A P35348 2/20 0.48
▸ HRH1 P35367 2/20 0.48
▸ HRH3 Q9Y5N1 2/20 0.48
▸ ADRA1B P35368 1/20 0.47
▸ CHRNB1 P11230 3/20 0.47
▸ CHRNB2 P17787 3/20 0.47
▸ CHRNB3 Q05901 3/20 0.47
▸ HTR1A P08908 2/20 0.45
▸ HTR1B P28222 2/20 0.45
▸ CHRNA4 P43681 2/20 0.44
▸ HTR6 P50406 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31079472 1.00 HTR2A (0.51) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL31079609 1.00 HTR2A (0.51) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL27165646 1.00 HTR2A (0.51) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL27165370 1.00 HTR2A (0.51) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL27165389 0.83 HTR2A (0.46) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL27204460 0.83 HTR2A (0.46) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL27204372 0.83 HTR2A (0.49) HTR2AHTR2CCHRM2CHRM1CHRNB4
SCHEMBL27165366 0.83 HTR2A (0.49) HTR2AHTR2CCHRM2CHRM1CHRNB4
SCHEMBL30816422 0.79 KDM4E (0.46) HTR2AHTR2CHTR2BCHRM2CHRM1
SCHEMBL7252886 0.77 HTR7 (0.42) CHRNB4CHRNA3HRH1HRH3CHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581018-A1 INDAZOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. (CA) 2025-07-09 — — EP disclosed
WO-2024044848-A1 INDAZOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO MINDSET PHARMA INC. (CA) 2024-03-07 — — WO disclosed
Send feedback